Wealth Enhancement Advisory Services LLC Boosts Stock Holdings in CVS Health Corporation $CVS

Wealth Enhancement Advisory Services LLC raised its position in CVS Health Corporation (NYSE:CVS) by 186.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 396,368 shares of the pharmacy operator’s stock after purchasing an additional 258,050 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in CVS Health were worth $30,568,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the company. Nippon Life Global Investors Americas Inc. grew its stake in CVS Health by 22.9% during the 3rd quarter. Nippon Life Global Investors Americas Inc. now owns 89,250 shares of the pharmacy operator’s stock worth $6,729,000 after buying an additional 16,650 shares during the last quarter. Resonant Capital Advisors LLC increased its holdings in shares of CVS Health by 3.9% in the 3rd quarter. Resonant Capital Advisors LLC now owns 4,233 shares of the pharmacy operator’s stock worth $319,000 after acquiring an additional 158 shares during the period. Harel Insurance Investments & Financial Services Ltd. lifted its position in CVS Health by 2,465.0% in the 3rd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 7,695 shares of the pharmacy operator’s stock valued at $579,000 after purchasing an additional 7,395 shares during the last quarter. Bank Hapoalim BM boosted its stake in CVS Health by 8.8% during the 3rd quarter. Bank Hapoalim BM now owns 4,265 shares of the pharmacy operator’s stock valued at $322,000 after purchasing an additional 345 shares during the period. Finally, Maryland State Retirement & Pension System increased its stake in shares of CVS Health by 1.9% in the third quarter. Maryland State Retirement & Pension System now owns 62,017 shares of the pharmacy operator’s stock valued at $4,675,000 after purchasing an additional 1,142 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Up 0.2%

CVS stock opened at $80.27 on Wednesday. CVS Health Corporation has a 52-week low of $52.34 and a 52-week high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm has a market capitalization of $101.90 billion, a P/E ratio of 211.25, a P/E/G ratio of 0.72 and a beta of 0.48. The company’s 50 day simple moving average is $78.86 and its 200-day simple moving average is $74.51.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the prior year, the company earned $1.09 earnings per share. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s dividend payout ratio is 700.00%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CVS shares. Wells Fargo & Company decreased their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Jefferies Financial Group raised their target price on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Evercore ISI increased their price objective on shares of CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Finally, The Goldman Sachs Group upped their target price on CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $94.86.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.